Piperazine ferulate inhibits diabetic nephropathy by suppressing AGE/RAGE-mediated inflammatory signaling in rats and podocytes

• Váldodahkkit: Xiu-Meng Zhang (Dahkki), Xin-Ran Min (Dahkki), Hong-Xiao Xie (Dahkki), Yan-Ning Jiang (Dahkki), Yi-Xin Rui (Dahkki), Bo Li (Dahkki), Nan Zeng (Dahkki), Rong Liu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Objective: Diabetic nephropathy (DN) is a serious complication that may occur during the later stages of diabetes, and can be further exacerbated by podocyte damage. Piperazine ferulate (PF) has well-defined nephroprotective effects and is used clinically in the treatment of chronic nephritis and ot...